2-Bromo-5-chloro-3-methylpyrazine

Catalog No. :
ACVTLN826
CAS No. :
1260664-82-1
Molecular Formula :
C5H4BrClN2
Molecular Weight :
207.46

IUPAC Name:2-bromo-5-chloro-3-methylpyrazine

2-Bromo-5-chloro-3-methylpyrazine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg98%$54.00Login to see priceIn stockInquiry
1g98%$174.00Login to see priceIn stockInquiry
5g98%$794.00Login to see priceIn stockInquiry
10g98%$1586.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-Bromo-5-chloro-3-methylpyrazine
IUPAC Name2-bromo-5-chloro-3-methylpyrazine
MDL No.MFCD18250174
Molecular FormulaC5H4BrClN2
Molecular Weight207.46
SMILESCC1=C(Br)N=CC(Cl)=N1
InChI KeyDDXSLISYCFTQCY-UHFFFAOYSA-N
SynonymDTXSID00855734 | 1260664-82-1 | SCHEMBL19785236 | AS-10302 | SY071182 | AB72477 | MFCD18250174 | Pyrazine, 2-bromo-5-chloro-3-methyl- | AKOS016008756 | 2-Bromo-5-chloro-3-methylpyrazine | FT-0725137 | CS-0186584
CAS No.1260664-82-1
PubChem CID71463842

Safety Data

Pictogram
Toxic
Signal Word
Gefahr
Hazard Statement(s)
H301-H311-H331
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P310-P330-P361-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACVTLN826 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACCWDA697 route compound structure diagram
    ACCWDA69713061-96-6
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACVTLN826 route product structure diagram
    ACVTLN8261260664-82-1 In Stock
Inquiry

2. ACVTLN826 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACGBMQ708 route compound structure diagram
    ACGBMQ7081206249-40-2 In Stock
  4. Then
  5. ACVTLN826 route product structure diagram
    ACVTLN8261260664-82-1 In Stock
Inquiry

Comments (0)